<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363523">
  <stage>Registered</stage>
  <submitdate>21/01/2013</submitdate>
  <approvaldate>21/01/2013</approvaldate>
  <actrnumber>ACTRN12613000078752</actrnumber>
  <trial_identification>
    <studytitle>The ATTEND Trial: Family-Led Rehabilitation after stroke in India
</studytitle>
    <scientifictitle>The ATTEND Trial: The effects of a Family-Led Rehabilitation on death or dependency at six months in participants with stroke in India</scientifictitle>
    <utrn>U1111-1138-6707</utrn>
    <trialacronym>ATTEND</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Stroke</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Haemorrhagic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Other physical medicine / rehabilitation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients allocated to Early Supported Discharge and family rehabilitation will have their family nominated caregiver trained by a specially trained stroke trial care coordinator health professional (i.e. nurse, therapist) using a designed structured assessment (cognition, language, function and mobility) and recommended rehabilitation package.  The package will include a structured check-list and culturally appropriate manual covering the key activities relevant to daily living (e.g. positioning, transfers, mobilisation, feeding, dressing, activity and motor practice, and monitoring of mood etc).  Training will begin in hospital and is envisaged to take ~60 mins per day for up to 3 days, with the intention of accelerating the patients hospital discharge when it is safe to do so.  The stroke trial care coordinator will visit (or arrange for other community workers to visit) the patient and caregivers, allocated Early Supported Discharge, up to 6 occasions to monitor progress post-discharge and will be available by telephone for support and guidance as the patient progresses over the next 3 months. </interventions>
    <comparator>The control patients will receive usual care. In general this usually consists of investigation and initial stabilisation of the patient, multidisciplinary assessment, a team meeting and formulation of a multidisciplinary plan, with an early discharge home and an offer of out-patient rehabilitation. Few (10%) patients are able to return to the out-patient rehabilitation service due to family commitments, and so some families pay for private physiotherapy in the home. It is likely that most patients in the control group will not have routine access to post-discharge stroke services.</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Effects of treatment on death or dependency (on the modified Rankin Scale [mRS]) at 6 months post-randomisation (mRS 0-2 versus 3-6)</outcome>
      <timepoint>Six months after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Effect of treatment on shift of disability, as measured by the mRS, and analysed with shift (ordinal) analysis  </outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The simple validated recovery (Have you made a complete recovery from your stroke?) and dependency (Do you need help from another person for everyday activities) questions</outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Place of residence will be noted at the face-to-face follow-up by the blinded assessor. Telephone follow-up will be performed if home visit not possible.</outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The Barthel Index to measure activities of daily living</outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Caregiver Strain Index </outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Expected serious events: 1) deaths categorized as vascular (stroke, MI, other vascular), infection, fracture, other and 2) Hospitalisation (stroke, MI, other vascular, infection, fracture, other). The hospitalised events will be identified by clinical assessment at the routine 3 and 6 month face-to-face assessments by the blinded assessor. Telephone follow-up will be performed if home visit not possible. </outcome>
      <timepoint>Events occurring in the six months following randomisation. These will be assessed for two time periods: 3 and 6 months after randomisation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health-related quality of life (WHOQOL-BREF and EQ-5D)</outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient and caregiver mood (Hospital Anxiety and Depression Scale)</outcome>
      <timepoint>Six months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Extended activities of daily living (Nottingham Extended ADL Scale) </outcome>
      <timepoint>Six months after stroke</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health care resource use (visits to health professionals, hospitalization, and medication use) and direct (e.g. payment to the caregiver to act as carer for this patient, total direct costs of healthcare paid by the family since time of stroke). These events will be identified by clinical assessment at the routine 3 and 6 month face-to-face assessments by the blinded assessor. Telephone follow-up will be performed if home visit not possible. </outcome>
      <timepoint>These events will be identified by clinical assessment at the routine 3 and 6 month face-to-face assessments by the blinded assessor. Telephone follow-up will be performed if home visit not possible. Events up to six months following randomisation will be included, i.e. the end of the study for each participant.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Indirect costs (e.g. family member giving up paid employment to act as caregiver) on the family. The use of family member diaries will be encouraged to collect this data.</outcome>
      <timepoint>For the six month period following randomisation. These costs will be identified by assessment at the routine 3 and 6 month face-to-face visits by the blinded assessor. Telephone follow-up will be performed if home visit not possible. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Direct Medical Costs (e.g. total expenditure during hospital admission which includes first place where patient was taken, general or private admission, length of hospital stay, admission charges, investigation charges and drug treatment). Participants will be encouraged to keep copies of the bills for these items.</outcome>
      <timepoint>These costs will be collected for the admission that led to randomisation and all subsequent costs up to six months after randomisation. These costs will be identified by assessment at the routine 3 and 6 month face-to-face visits by the blinded assessor. Telephone follow-up will be performed if home visit not possible. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Non-medical direct cost (e.g. travelling costs). The use of family member diaries will be encouraged in order to collect these costs.</outcome>
      <timepoint>For the six months following randomisation. These costs will be identified by assessment at the routine 3 and 6 month face-to-face visits by the blinded assessor. Telephone follow-up will be performed if home visit not possible. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Additional secondary outcomes will include all our 6 month outcomes (both primary and secondary outcomes) measured at 3 months following randomisation.</outcome>
      <timepoint>3 months following randomisation. Our outcomes will be measured by our blinded assessor at a face-to-face visit, or telephone follow-up if a home visit was not possible.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hospital length of stay</outcome>
      <timepoint>The length of hospital admission for the admission that included the date of randomisation will be determined by access to the medical records at the randomising hospital</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adults (=18 years);
Recent (&lt;1 month) acute ischaemic/haemorrhagic/undifferentiated stroke;
Residual disability (requiring help from another person for everyday activities).
Expected to survive to discharge from hospital with a reasonable expectation of 6 month survival (i.e. not palliative, no evidence of widespread cancer etc.); 
Able (or by proxy) to provide informed consent.
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to identify a suitable family-nominated caregiver for training and subsequent delivery of care;
Those unwilling/unable to adhere to follow-up.
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Eligible patients will be randomised within 7 days of hospital admission, using a secure, central, password protected, internet-based computerised system.</concealment>
    <sequence>The computerised randomisation system will be based at The George Institute for Global Health with a random allocation stratified by centre and stroke severity</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>The intention to treat (ITT) principle will be applied in all analyses. The primary end-point is the proportion of those dead or dependent (as measured on the modified Rankin score (mRS)) at 6 months. This will be analysed using an unadjusted logistic regression model. Binary secondary outcomes will be analysed similarly, with analysis of variance (t-tests) used for continuous variables. For the shift analysis of mRS using all seven categories (including 6 for death), ordinal logistic regression, after verifying the proportional odds assumption, will be used.</statisticalmethods>
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>1/07/2013</anticipatedstartdate>
    <actualstartdate>13/01/2014</actualstartdate>
    <anticipatedenddate>12/02/2016</anticipatedenddate>
    <actualenddate>12/02/2016</actualenddate>
    <samplesize>1200</samplesize>
    <actualsamplesize>1250</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate>14/10/2016</anticipatedlastvisitdate>
    <actuallastvisitdate>18/10/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>India</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>The George Institute for Global Health</primarysponsorname>
    <primarysponsoraddress>PO Box M201
Missenden Rd 
NSW 2050 
Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council of Australia (NHMRC)</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601
</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This Project is to evaluate an affordable post-stroke rehabilitation program in a large randomised controlled trial (RCT), that, if shown to be effective, could be rolled out throughout India.

Our study design is a multicentre, randomised, blinded outcome assessor, controlled trial of Early Supported Discharge (ESD) with a trained family-led caregiver-delivered, home-based stroke rehabilitation compared to usual care in at least 1200 patients with mild-moderate disability recruited from about 12 sites in India. 

Eligible patients will be adults (=18 years), with recent  (&lt;1 month) acute stroke, who have residual disability, are expected to survive to discharge from hospital with at least 6 month survival and are able (or by proxy) to provide informed consent.

Randomisation:  Eligible patients will be randomised within 7 days of hospital admission.
Intervention arm:  Patients allocated to ESD and family rehabilitation will have their family nominated caregiver trained by a specially trained stroke trial care coordinator health professional (i.e. nurse, therapist) using a designed structured assessment (cognition, language, function and mobility) and recommended rehabilitation package.  The package will include a structured check-list and culturally appropriate manual covering the key activities relevant to daily living (e.g. positioning, transfers, mobilisation, feeding, dressing, activity and motor practice, etc).  Training will begin in hospital and is envisaged to take ~60 mins per day for 3 days, with the intention of accelerating the patients hospital discharge when it is safe to do so.  The stroke trial care coordinator will visit (or arrange for other community workers to visit) the patient and caregivers up to 6 occasions to monitor progress post-discharge and will be available by telephone for support and guidance as the patient progresses over the next 3 months.
The primary outcome measure will be independent survival measured at 6 months after randomisation.
</summary>
    <trialwebsite />
    <publication>Statistical analysis plan for the family-led rehabilitation after stroke in India (ATTEND) trial: A multicentre randomized controlled trial of a new model of stroke rehabilitation compared to usual care. Billot L, Lindley RI, Harvey LA, Maulik PK, Hackett ML, Murthy GVS, Anderson CS, Shamanna BR, Jan S, Walker M, Forster A, Langhorne P, Verma SJ, Felix C, Alim M, Gandhi DBC Pandian JD. Int J Stroke 2017; 12: 208-210
Family-led rehabilitation after stroke in India: A Randomized Controlled Trial. Lindley RI, et al.. Lancet 2017. Published Online June 27, 2017 http://dx.doi.org/10.1016/ S0140-6736(17)31447-2.Â Lancet 2017; 390: 588-599. </publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Institutional Ethics Committee, Christian Medical College and Hospital, Ludhiana</ethicname>
      <ethicaddress>Christian Medical College, Ludhiana - 141 008
Punjab
India</ethicaddress>
      <ethicapprovaldate>12/12/2012</ethicapprovaldate>
      <hrec>N/A</hrec>
      <ethicsubmitdate />
      <ethiccountry>India</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of Sydney</ethicname>
      <ethicaddress>Level 6 Jane Foss Russell Building
The University of Sydney
NSW2006</ethicaddress>
      <ethicapprovaldate>9/04/2013</ethicapprovaldate>
      <hrec>2013/248</hrec>
      <ethicsubmitdate>25/03/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Richard Iain Lindley</name>
      <address>The George Institute for Global Health and The University of Sydney
PO Box M201
Missenden Rd
NSW 2050 
Australia</address>
      <phone>+61 2 9845 5080</phone>
      <fax>+61 2 96570301</fax>
      <email>rlindley@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Richard Iain Lindley</name>
      <address>The George Institute for Global Health and The University of Sydney
PO Box M201
Missenden Rd
NSW 2050 
Australia</address>
      <phone>+61 2 9845 5080</phone>
      <fax>+61 2 96570301</fax>
      <email>rlindley@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Richard Iain Lindley</name>
      <address>The George Institute for Global Health and The University of Sydney
PO Box M201
Missenden Rd
NSW 2050 
Australia</address>
      <phone>+61 404 866 007</phone>
      <fax>+61 2 96570301</fax>
      <email>rlindley@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Richard Iain Lindley</name>
      <address>The George Institute for Global Health and The University of Sydney
PO Box M201
Missenden Rd
NSW 2050 
Australia</address>
      <phone>+61 2 9845 5080</phone>
      <fax>+61 2 96570301</fax>
      <email>rlindley@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>